Coronary angiography +/- percutaneous coronary intervention
ProcedureCoronary angiography +/- percutaneous coronary intervention
NCT Number: NCT05605288
Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed for undertaking percutaneous coronary angiography and interventions. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium
Gaining vascular access is the first, mandatory step for undertaking percutaneous coronary angiography and interventions. The recent guidelines, published by European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), propose TRA as the gold standard for acute coronary syndromes (ACS), chronic coronary syndrome (CCS) percutaneous coronary interventions (PCI). Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Mutual point of all the previous RCTs is that excluded patients suffering from ST-elevation Myocardial Infraction (STEMI). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Coronary angiography +/- percutaneous coronary intervention
Time frame: Immediately post-procedurally
needle-to-wire time
Time frame: The evaluation will be performed during hospitalization for STEMI and prior discharge, typically the 4th day after PCI
Radial artery patency evaluation with Doppler ultrasound prior to hospital discharge for detecting possible occlusion after cannulation
Time frame: Immediately post-procedurally
Crossover rate from distal transradial artery access to other access point
Time frame: Immediately post-procedurally
Duration required from the beginning of puncture until sheath insertion
Time frame: Immediately post-procedurally
Total duration of coronary angiography and angioplasty
Time frame: Immediately post-procedurally
The time interval between the initiation of radial artery puncture and the completion of coronary angiography, until the beginning of the possible PCI
Time frame: Immediately post-procedurally
Required time for coronary angiography completion, after sheath insertion
Time frame: Immediately post-procedurally
Required time percutaneous coronary intervention completion
Time frame: Immediately post-procedurally
Total fluoroscopy time
Time frame: Immediately post-procedurally
Total Dose Area Product (DAP)
Time frame: Immediately post-procedurally
Air Kerma
Time frame: 3 hours
Time required for achieving hemostasis
Time frame: 24 hours
Vascular complications
Time frame: 24 hours
Hematomas classification using modified EASY which is compatible with dTRA
Time frame: 30 days
30-days Clinical follow-up (on site or via telephone call)
University Hospital of Patras
Other
Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With ST-elevation Myocardial Infraction (STEMI): The DR-STEMI Trial
Acronym: DR-STEMI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05781087
Arterial Occlusive Diseases, Arteriosclerosis
Bournemouth, United Kingdom
View Trial DetailsNCT04573751
Cardiovascular Diseases, Heart Diseases
Tomsk, Tomsk Oblast, Russia
View Trial DetailsNCT04665648
Cardiovascular Diseases, Heart Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01149044
Acute Coronary Syndrome, Cardiovascular Diseases
Bakersfield, California, United States
View Trial Details